The number has doubled in just 3 years as Gov. LePage and other state leaders continue a pattern of slow response to the crisis.
opioid epidemic
Posted inEditorials, Opinion
Our view: ‘Health homes’ come up short in opioid fight
The state’s answer to the overdose crisis is not reaching the people it’s intended to help.
advertisement
Posted inLocal & State
Bill would remove veterinarians from Maine opioid monitoring law
The bill would no longer require veterinarians to look up the prescription history of the pet owner before prescribing an opioid for an animal.
Posted inLocal & State, News
Day One of South Portland opening youth treatment center in New Gloucester
The nonprofit plans to provide substance abuse treatment and counseling services to 8-12 Maine men ages 14-20.
Posted inLocal & State, News, Politics
After a year, LePage program to treat opioid addicts falling far short of target
The $4.8 million program has been stifled by bureaucracy, according to a group representing treatment providers.
Posted inNation & World, News
Opioid-related deaths in Massachusetts fell by 8 percent during 2017
A law passed last year created new rules for prescribing the drugs and made a new prescription monitoring program.
Posted inEditorials, Opinion
Our View: Trump’s plan to fight opioids has a lot to like
His spending plan embraces promising ideas, like greater funding for and access to treatment – but it takes a big step back by attempting to repeal Obamacare and cut Medicaid.
Posted inMaine Voices, Op-eds, Opinion
Maine Voices: Bill to aid substance-exposed infants would benefit women also
The legislation is one part of what must be a sensitive, multipronged fight to aid health and recovery.
Posted inBill Nemitz, Local & State, News, Opinion
Bill Nemitz: LePage should put people who overdose before politics
Maine’s bullheaded governor insists that naloxone, rather than saving lives, only delays inevitable deaths.
Posted inOp-eds, Opinion
Portland Sen. Chipman: Governor shouldn’t play politics with Mainers’ lives
LePage is holding up rules that would increase access to the life-saving anti-overdose drug naloxone.